Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Publications

Can artificial intelligence accelerate the diagnosis of inherited retinal diseases? Protocol for a data-only retrospective cohort study (Eye2Gene).

Nguyen Q. et al, (2023), BMJ Open, 13

INCREASING EVIDENCE FOR THE SAFETY OF FOVEA-INVOLVING HALF-DOSE PHOTODYNAMIC THERAPY FOR CHRONIC CENTRAL SEROUS CHORIORETINOPATHY

Feenstra HMA. et al, (2023), Retina, 43, 379 - 388

Intraretinal Microvascular Abnormalities and Venous Beading Have Different Genetic Profiles in Caucasian Patients with Non-Proliferative Diabetic Retinopathy

Pearce E. et al, (2023), Vision (Switzerland), 7

Faricimab in neovascular AMD: first report of real-world outcomes in an independent retina clinic

Stanga PE. et al, (2023), Eye (Basingstoke)

Multimodal Analysis of the Visual Pathways in Friedreich's Ataxia Reveals Novel Biomarkers.

Thomas-Black G. et al, (2022), Mov Disord

The inner junction protein CFAP20 functions in motile and non-motile cilia and is critical for vision.

Chrystal PW. et al, (2022), Nat Commun, 13

A nationwide survey of hydroxychloroquine retinopathy presenting to the hospital eye service in the United Kingdom

YUSUF I. et al, (2022), Eye

Phenotypic and Genetic Characteristics in a Cohort of Patients with Usher Genes

Feenstra HM. et al, (2022), Genes, 13, 1423 - 1423

Spontaneous Resolution of Chronic Central Serous Chorioretinopathy: "Fuji Sign".

Feenstra HMA. et al, (2022), Ophthalmology. Retina

EFFICACY OF HALF-DOSE PHOTODYNAMIC THERAPY VERSUS HIGH-DENSITY SUBTHRESHOLD MICROPULSE LASER FOR TREATING PIGMENT EPITHELIAL DETACHMENTS IN CHRONIC CENTRAL SEROUS CHORIORETINOPATHY.

Feenstra HMA. et al, (2022), Retina (Philadelphia, Pa.), 42, 721 - 729

Long term retinal morphology and functional associations in treated neovascular age-related macular degeneration: findings from the IVAN trial.

Peto T. et al, (2022), Ophthalmol Retina

The Natural History of Leber Congenital Amaurosis and Cone-Rod Dystrophy Associated with Variants in the GUCY2D Gene.

Hahn LC. et al, (2022), Ophthalmol Retina

Late-Onset Autosomal Dominant Macular Degeneration Caused by Deletion of the CRX Gene

Yahya S. et al, (2022), Ophthalmology

Rapid Quantification of the Binocular Visual Field for Clinical Trials: Performance of a Modified Esterman Supra-Threshold Test Implemented with the Open Perimetry Interface.

Andrews CD. et al, (2022), Clin Ophthalmol, 16, 1513 - 1523

The need for widely available genomic testing in rare eye diseases: an ERN-EYE position statement

Black GC. et al, (2021), Orphanet Journal of Rare Diseases, 16

Whole genome sequencing in a Knobloch syndrome family confirms the molecular diagnosis.

Patel CK. et al, (2021), Ophthalmic Genet, 1 - 9

SVRare: discovering disease-causing structural variants in the 100K Genomes Project

Yu J. et al, (2021)

RESPONSE OF CHOROIDAL ABNORMALITIES TO PHOTODYNAMIC THERAPY VERSUS MICROPULSE LASER IN CHRONIC CENTRAL SEROUS CHORIORETINOPATHY: Place Trial Report No. 4.

van Rijssen TJ. et al, (2021), Retina, 41, 2122 - 2131

An Overview of the Genetics of ABCA4 Retinopathies, an Evolving Story

Al-Khuzaei S. et al, (2021), Genes, 12, 1241 - 1241

Bilateral paracentral acute middle maculopathy in a SARS-CoV-2-positive patient.

Naughton A. et al, (2021), Postgrad Med J

Load More

1
2
3
4
5
6
7
...
»

Include forthcoming?